Dublin, Ireland--(Newsfile Corp. - June 24, 2025) - Cosmo Pharmaceuticals N.V. (“Cosmo”) today announced that in July 2025, it will initiate their first usability study of a medical device software ...

Dublin, Ireland--(Newsfile Corp. - September 2, 2024) - Cosmo Intelligent Medical Devices (Cosmo IMD), a division of Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”), the developer and ...

Agreement expands partnership between Medtronic and Cosmo Pharmaceuticals, set to transform endoscopy with cutting-edge AI technology DUBLIN, Dec. 11, 2023 /PRNewswire/ -- Medtronic plc (MDT) (NYSE: ...

Please provide your email address to receive an email when new articles are posted on . Mean number of adenomas per procedure was higher with GI Genius vs. standard colonoscopy (1.56 vs. 1.21), as was ...

Medtronic has entered a definitive agreement to expand its partnership with Cosmo Intelligent Medical Devices to further capitalize on the achievements of Medtronic’s GI Genius intelligent endoscopy ...

Cosmo Pharmaceuticals aims to make the colonoscopy a little more up close and personal, for providers anyway, by connecting its artificial-intelligence-powered video module with Apple’s virtual ...

Healthcare technology company Medtronic will partner with Cosmo Pharmaceuticals’ medical device business unit to expand the use of artificial intelligence. The partnership will build off of the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Use of GI Genius increased mean adenomas per colonoscopy ...